Navigation Links
AstraZeneca Applauds Appointment of New FDA Commissioner
Date:3/14/2009

WILMINGTON, Del., March 14 /PRNewswire-FirstCall/ -- Today AstraZeneca (NYSE: AZN) released the following statement in response to the appointment of a new FDA Commissioner:

"AstraZeneca applauds the appointment of Dr. Peggy Hamburg as Commissioner of the Food and Drug Administration. Dr. Hamburg will bring a wealth of experience and knowledge that will serve the agency well in these challenging times. AstraZeneca is pleased that President Obama is acting swiftly to appoint a leader with critical responsibilities for consumer protection and innovation.

"In this remarkable new age of scientific innovation, AstraZeneca stands for a strong, well-funded FDA. AstraZeneca is committed to working with Congress, the administration and the FDA to ensure the agency has the resources it needs to protect patients by effectively reviewing life-saving and enhancing medications.

"AstraZeneca is a founding member of the Alliance for a Stronger FDA, a coalition of consumer, patient, professional and research groups, industry trade associations and individuals who support increased Congressional funding for FDA."

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me(TM) Prescription Savings programs, please visit: www.a
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. AstraZeneca Leads Local Walking Movement
2. AstraZeneca Joins Local Walking Movement
3. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
4. Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
5. AstraZeneca Recognized as One of Working Mothers 100 Best Companies for the Sixth Consecutive Year
6. AstraZeneca Launches New Program to Support Facilities that Connect People to Needed Medical Care and Prescription Assistance
7. NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
8. Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca
9. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
10. AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
11. AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... TX (PRWEB) June 19, 2013 Chrysler made ... concerning a recall of 2.7 million Jeeps. The Jeep models ... 2002-2007 Jeep Liberty, which according to the NHTSA are vulnerable ... gas tanks in these models are rear-mounted and have been ... agency findings show the Grand Cherokee with 32 rear-end crashes, ...
(Date:6/19/2013)... June 19, 2013 Amber Roberson ... RWI Benefits, LLC, Native Care Health, LLC and ... of Health Underwriters’ (NAHU) new professional development course ... (PPACA). This continuing education course for agents has ... will receive eleven education credits from the Missouri ...
(Date:6/19/2013)... New York, New York (PRWEB) June 19, 2013 ... involving pancreatitis and pancreatic cancer continue to mount in ... the U.S. Food & Drug Administration (FDA) recently held ... other diabetes drugs known as incretin mimetics. According ... may seek additional data from the makers of Januvia ...
(Date:6/19/2013)... 2013 The Journal of Parasitology – ... computer software, it creates questions of ethics. For scientific ... an already published case shows, scientific publications need clear ... The Journal of Parasitology features a commentary ... 2004 article published in the Journal of the New ...
(Date:6/19/2013)... led by researchers at The University of Texas MD ... show remarkable promise for the treatment of relapsed or ... interim findings of the 18-center Phase 2 study were ... Medicine . Previous interim findings were presented in December ... Meeting and Exposition. , Unprecedented results, fewer ...
Breaking Medicine News(10 mins):Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 2Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 3Health News:RWI Benefits, LLC Becomes PPACA Certified 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2
... it has been found that students who are well fed ... ,The study was done at Cornell's Early Childhood Centre. ... development especially in reading. ,This phenomenon is ... do not have enough to eat due to poverty in ...
... treatment medicine acclaimed the world over Tamiflu now will be ... firm Roche to make a generic version of its anti-flu ... The company is Hetero Drugs. ,The drug is ... future pandemic of bird flu in humans. ,The Swiss drugs ...
... Indian American Scientist Dr. Henry Daniell has produced a ... plant. The new gene transfer technique to tobacco plants ... symptoms and rashes involved in conventional anthrax vaccine fermentation ... of 360 million doses in one acre of tobacco ...
... company that extracts chemicals from plants, plans to use used ... drug that treat bird flu.// ,The trees contain ... Biolyse said today in a statement. The acid is used ... star anise trees in China, Biolyse said. ,Tamiflu ...
... larger brains have better intellect, according to McMaster University’s ... said that there were differences between women and men. ... Brain also said, said that in women, verbal intelligence ... of the verbal IQ score. ,However, ...
... of the rising rates of infection with C.difficile among ... mutation of the microorganism into a more virulent form.// ... manifest in individuals with resistance to antibiotics. ... non-hospitalized patients has created much panic among the scientific ...
Cached Medicine News:Health News:Christmas trees to yield key Tamiflu ingredient 2Health News:Rising Rates Of C.Difficile Infection Among Non-Hospitalized Patients 2
(Date:6/19/2013)... 19, 2013 Ellen MacArthur ... kommande tre åren kommer att vara en partner ... cirkulär ekonomi. Efter stiftelsens framgångsrika partnerskap ... Grid, kommer Philips att ansluta sig som partner ... i sin egen verksamhet och stödja stiftelsens arbete ...
(Date:6/19/2013)... , June 19, 2013 The Physician-Patient Alliance ... alarm fatigue. The need to urgently address this ... its Sentinel Event Alert #50 , "Medical device alarm safety ... database, between January 2008 and June 2012, there were 98 ... resulted in death (82%) , 13 resulted in permanent ...
(Date:6/19/2013)... , June 19, 2013   BioCision , ... standardization and handling in many areas of medical ... new patents by the U.S. Patent Office that ... developed to standardize sample handling to ensure the ... in common laboratory procedures. Patent ...
Breaking Medicine Technology:Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 2Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 3Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2
... April 14, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. ... Company") a leading manufacturer of medical dressings, medical disposables ... in China, today announced that the Company will attend ... Exhibition to be held in the Shenzhen Convention and ...
... Reportlinker.com announces that a new market research ... Endometrial Cancer Therapeutics - Pipeline Assessment and ... http://www.reportlinker.com/p0479825/Endometrial-Cancer-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2017.html Endometrial Cancer Therapeutics - ... Summary GlobalData, the ...
Cached Medicine Technology:Winner Medical to Attend 65th CMEF Spring11 Exhibition in Shenzhen 2Winner Medical to Attend 65th CMEF Spring11 Exhibition in Shenzhen 3Winner Medical to Attend 65th CMEF Spring11 Exhibition in Shenzhen 4Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 8Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 9Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017 10
The Advia 60 is designed to deliver powerful performance in a small package....
AcT 5diff OV enables low-volume labs to advance to 5-part differential analysis at an affordable price. This analyzer delivers accurate test results and a user-friendly software interface in a compac...
... three-dimensional VCS technology, providing ... efficiency in white cell ... With its reputation for ... is an affordable solution ...
... 750 analyzer is equipped with ... random access capabilities. These advancements ... pre-sorting of samples and speed ... system, you can improve overall ...
Medicine Products: